Arkolith/Insider Trading/VNDA/Form 4

Mitchell Stephen Ray

DirectorVanda Pharmaceuticals Inc. (VNDA) · full profile →Form 4 · filed Aug 11, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$39K
Net Open-Market Flow
-$39K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 10, 2023Sell(S)7K$6.05$39K29K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-23-045447) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML